• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway

    GLOBENEWSWIRE

    Anti-Properdin Antibody Demonstrates Efficacy in Model of Wet-AMD and Dry-AMD

    GLOBENEWSWIRE

    NM3086 Reduced Hemolysis, LDH, in an Animal Model of PNH- a Rare Disease

    PRNEWSWIRE

    Alternative Pathway Blocker NM8074 Receives FDA Clearance for Efficacy Trial

    PRNEWSWIRE

    NovelMed reports interim positive data from Phase I trial of PNH asset

    CLINICALTRIALSARENA

    NovelMed Announces Interim Positive Results from Its Phase I Trial of NM8074

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.